Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery
1 other identifier
interventional
8
1 country
1
Brief Summary
This is a study of the feasibility of activating the auditory system by an electrode in direct contact with the cochlear nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2022
CompletedFirst Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
February 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedDecember 1, 2022
November 1, 2022
2.1 years
February 9, 2022
November 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Auditory brainstem response
Electrical potentials recorded with scalp electrodes in response to electrical stimulation of the cochlear nerve
Recorded immediately during ongoing cochlear-nerve stimulation
Study Arms (1)
Intraoperative electrical stimulation of cochlear nerve
EXPERIMENTALElectrical stimulation of the cochlear nerve will be tested intraoperatively in patients undergoing vestibular schwannoma resection.
Interventions
Intraoperative electrical stimulation of the cochlear nerve in patients undergoing surgery for resection of vestibular schwannoma. Activation of the auditory system monitored with scalp recording of auditory brainstem response.
Eligibility Criteria
You may qualify if:
- Adults with the diagnosis of unilateral or bilateral vestibular schwannoma proven on radiographic imaging.
- Only patients with little or no hearing ability undergoing surgical resection of the tumor will be enrolled.
You may not qualify if:
- Women who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Irvine Health, Pavilion II
Orange, California, 92868, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harrison M Lin, MD
University of California, Irvine
- PRINCIPAL INVESTIGATOR
John C Middlebrooks, PhD
University of California, Irvine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 9, 2022
First Posted
February 21, 2022
Study Start
January 25, 2022
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
December 1, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share